NASDAQ:SPHS - Nasdaq -
0.23
-0.35 (-60.3%)
The current stock price of SPHS is 0.23 null. In the past month the price decreased by -65.86%. In the past year, price decreased by -78.5%.
Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.
Sophiris Bio Inc.
1258 PROSPECT STREET
LA JOLLA CA 92037
CEO: Randall E. Woods
Phone: 858-777-1760
The current stock price of SPHS is 0.23 null. The price decreased by -60.3% in the last trading session.
The exchange symbol of Sophiris Bio Inc. is SPHS and it is listed on the Nasdaq exchange.
SPHS stock is listed on the Nasdaq exchange.
Sophiris Bio Inc. (SPHS) has a market capitalization of 8.18M null. This makes SPHS a Nano Cap stock.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SPHS does not pay a dividend.
Sophiris Bio Inc. (SPHS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.33).
ChartMill assigns a fundamental rating of 2 / 10 to SPHS. SPHS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months SPHS reported a non-GAAP Earnings per Share(EPS) of -0.33000000000000007. The EPS increased by 31.25% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | 0.52% | ||
ROE | N/A | ||
Debt/Equity | -1.12 |
ChartMill assigns a Buy % Consensus number of 100% to SPHS. The Buy consensus is the average rating of analysts ratings from 1 analysts.